SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRobot Corporation

A federal securities class action has been filed against iRobot Corporation (NASDAQ: IRBT), with a lead plaintiff deadline of September 5, 2025, for investors who acquired shares between January 29, 2024, and March 11, 2025. The complaint alleges iRobot made materially false and misleading statements regarding its Restructuring Plan's effectiveness post-Amazon acquisition termination, overstating its ability to profitably operate as a standalone company and failing to disclose substantial doubt about its going concern status. These allegations stem from iRobot's Q4 2024 results, which reported a $2.06 per share loss and a 44% year-over-year revenue decline to $172 million, leading to a 51.58% stock price drop over two trading sessions.

Analysis

iRobot Corporation is facing a severe crisis centered on a federal securities class-action lawsuit alleging that the company and its executives misled investors. The core of the complaint is that iRobot overstated the efficacy of its Restructuring Plan following the termination of the Amazon acquisition and failed to disclose significant doubts about its viability as a standalone entity. These allegations are substantiated by the company's own March 12, 2025, announcement, which reported a 44% year-over-year revenue decline to $172 million and a loss of $2.06 per share for Q4 2024. Critically, iRobot's management explicitly stated there is 'substantial doubt about the Company’s ability to continue as a going concern.' The market reaction was immediate and punitive, with the stock price plummeting 51.58% over two trading sessions. This combination of poor operational results, a dire forward-looking warning from the company itself, and subsequent legal action paints a picture of a company whose fundamental stability is in question.

Key Decisions for Investors

• Given the company's explicit 'going concern' warning and the precipitous 44% revenue decline, investors should critically reassess the viability of any long positions in IRBT.
• The pending securities class-action lawsuit introduces a significant litigation overhang that is likely to suppress the stock's valuation and drain management resources for the foreseeable future.
• Monitor future financial disclosures for any stabilization in revenue, improvement in cash burn, and updates on the restructuring plan's effectiveness, as these will be critical indicators of the company's potential for survival.
• Investors who purchased securities between January 29, 2024, and March 11, 2025, should evaluate their legal options regarding the class action to potentially recover losses.